SHS Gesellschaft für Beteiligungsmanagement mbH

Portfolio News

1. August 2023 - Newsletter, Portfolio News

SHS offers its portfolio companies a regular workshop for mutual exchange and training purposes

Another format that SHS has specifically created for its portfolio companies is the SHS portfolio workshops. These take place quarterly, covering various topics. The aim is to discuss topics that concern a large proportion of the portfolio companies and to provide the companies the opportunity to exchange ideas and knowledge, to discuss approaches to solving […]

Read more
1. August 2023 - Newsletter, Portfolio News

Salvia reports successful first application for the treatment of severe migraines in humans

Salvia BioElectronics, a pioneering Dutch company specialising in the treatment and cure of severe migraines, announced the successful first implantation of its paper-thin neuromodulation solution. Migraine is the most common cause of disability in people under 50 and affects one in seven people, mainly women. More than five percent of migraine patients suffer from chronic […]

Read more
1. August 2023 - Newsletter, Portfolio News

PathoQuest announces strategic partnership with Oxford Nanopore Technologies

French company PathoQuest has entered into a strategic partnership with Oxford Nanopore Technologies to bring to market the first sequencing-based quality control test for the genetic characterisation of biopharmaceuticals. Most biologics are produced using genetically modified cell lines. For many cell therapies, the product itself is a genetically modified cell line. Throughout the development of […]

Read more
23. March 2023 - Newsletter, Portfolio News

US launch for SIS super shock balloon OPN NC®

SIS Medical AG (Swiss Interventional Systems), a leading global developer, manufacturer and distributor of high-quality, high-performance interventional cardiology products, announces the US launch of its flagship product, the OPN NC® PTCA Dilatation Catheter with TWIN-Wall Technology. The product expands treatment options with high performance and safety, providing success rates where other balloons fail. The OPN […]

Read more
2. March 2023 - Portfolio News, SHS News

More patient safety with simulators for cardiologists – SHS invests 10 million euro in Swiss Simulands AG

SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]

Read more
8. December 2022 - Newsletter, Portfolio News

From Hippocrates to Blazejewski: Endoscopy in fast-forward mode

More than 510,000 colonoscopies for the early detection of colorectal cancer were performed in Germany in 2019. Compared to 2018, this was an increase of more than 14 percent. Screening colonoscopy plays an important role in the early detection of colorectal cancer. Today, the procedure itself is relatively uncomplicated and painless, thanks to state-of-the-art endoscopy […]

Read more
1
2345Next